In December, The Conversation hosted a webinar on AI's revolutionary role in drug discovery and development. Science and ...

A research team from Yale University in the U.S., in collaboration with global pharmaceutical company Boehringer Ingelheim, has developed an AI-based compound generation platform called MOSAIC, Nature ...

Christine Allen, CEO and Co-Founder of Intrepid Labs, and Andy Lewis, CSO at Quotient Sciences, highlight their strategic ...

The reference architecture connects enterprise and public scientific data to accelerate target identification and compound ...

The recent uptick in IPOs is an encouraging signal after a drought for much of 2025. Experts point to AI as a driving force ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: The corporate logo of the U.S. Food and Drug Administration (FDA) is shown in Silver Spring, Maryland, November 4, ...

Add Yahoo as a preferred source to see more of our stories on Google. The FDA and EMA's guidance on best practices for the use of AI in drug development recommend high-quality In a bid to optimise the ...

When patient safety, regulatory approval and real-world effectiveness are on the line, AI can't act autonomously.

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

In a bid to optimise the use of AI in drug development, US and European regulators have banded together to advise industry members on how best to incorporate the technology into their workflow. The ...